Reed Smith LLP

Multidistrict Litigation: What to Expect from JPML Consolidation Through Trial

Multidistrict Litigation: What to Expect from JPML Consolidation Through Trial
With more than half of all cases pending in the federal courts now docketed in multidistrict litigations (MDLs), companies facing large-scale litigation should expect to find themselves before the Judicial Panel on Multidistrict Litigation (JPML) with an MDL on the horizon. MDLs are common in product liability actions, but cover an expansive number of areas, including antitrust, air and common disasters, employment practices, intellectual property, sales practices, data security, and securities litigation.

Oradores:: Melissa A. Geist Jennifer A. Eppensteiner

Tipo de evento: Seminario web, Educación legal continua/desarrollo profesional continuo

Fecha/hora de inicio:
27 February 2018, 12:00 PM ET
Fecha/hora de finalización:
27 February 2018, 1:00 PM ET

This webinar will provide you with an introduction to JPML and MDL procedures, including the latest trends and strategic tips for maximizing efficiencies where possible. You will also learn about the effect MDL litigation can have on pending state court actions, as well as about best practices for coordination among federal and state court actions.

This program is presumptively approved for 1.0 general CLE credit in California, Illinois, New Jersey, Pennsylvania, Texas and West Virginia. For lawyers licensed in New York, this course is eligible for 1.0 credit under New York’s Approved Jurisdiction Policy. Please allow four weeks after the program to receive a certificate of attendance.

You May Be Interested

D.N.J Dismisses Fluoroquinolone False Claims Act Case
Drug & Device Law
17 April 2024
FCA Verdict Slashed as Unconstitutional Excessive Fine
Drug & Device Law
15 April 2024
Preemption and Recalls
Drug & Device Law
11 April 2024
Hip Implant MDL Remand Court Denies Plaintiff’s Request for Nonmutual Offensive Collateral Estoppel
Drug & Device Law
10 April 2024